stockrowAmarin Corporation PLC (AMRN) vs GSK PLC Sponsored ADR (GSK)
- Amarin Corporation PLC AMRN 11.61 +0.26%
- GSK PLC Sponsored ADR GSK 50.33 −0.16%
Amarin Corporation PLC and GSK PLC Sponsored ADR are both Drug Manufacturers General companies. GSK PLC Sponsored ADR is the larger, with a market value of $101.0B against $244.0M — 414.1× the size. Amarin Corporation PLC has negative trailing earnings, so its P/E is not meaningful; GSK PLC Sponsored ADR trades at 16.7×. GSK PLC Sponsored ADR grew revenue faster over the last twelve months: 6.90% against −22.3%. GSK PLC Sponsored ADR has the higher net margin (13.0% vs −10.9%) and the higher return on invested capital (9.61% vs −16.6%). Across the 21 metrics below, GSK PLC Sponsored ADR leads on 12 and Amarin Corporation PLC on 9.
Valuation
Profitability
| Metric | AMRN | GSK | Drug Manufacturers General median |
|---|---|---|---|
| Gross margin | 40.94% | 72.64% | 73.01% |
| Operating margin | (18.19%) | 17.95% | 18.34% |
| Net margin | (10.87%) | 13.02% | 7.31% |
| Free cash flow margin | 21.29% | 19.65% | 18.56% |
| Return on equity | (4.24%) | 25.48% | 5.80% |
| Return on assets | (2.96%) | 6.53% | 2.28% |
| Return on invested capital | (16.57%) | 9.61% | 6.26% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack